Blaess M, Csuk R, Schatzl T, Deigner H
Int J Mol Sci. 2024; 25(17).
PMID: 39273293
PMC: 11395647.
DOI: 10.3390/ijms25179344.
Yi J, Qi B, Yin J, Li R, Chen X, Hu J
Nat Commun. 2023; 14(1):7755.
PMID: 38012235
PMC: 10682184.
DOI: 10.1038/s41467-023-43580-w.
Yuan H, Zhu B, Li C, Zhao Z
Front Cell Neurosci. 2023; 17:1191609.
PMID: 37333888
PMC: 10272456.
DOI: 10.3389/fncel.2023.1191609.
Gorgani S, Hosseini S, Wang A, Baino F, Kargozar S
Materials (Basel). 2023; 16(11).
PMID: 37297327
PMC: 10254331.
DOI: 10.3390/ma16114194.
Ruisanchez E, Janovicz A, Panta R, Kiss L, Parkanyi A, Straky Z
Int J Mol Sci. 2023; 24(9).
PMID: 37176081
PMC: 10179569.
DOI: 10.3390/ijms24098375.
Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma.
Muhle C, Kornhuber J
Int J Mol Sci. 2023; 24(3).
PMID: 36768790
PMC: 9916453.
DOI: 10.3390/ijms24032467.
Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function.
Balazova M, Vesela P, Babelova L, Durisova I, Kanovicova P, Zahumensky J
Microbiol Spectr. 2022; 10(6):e0248922.
PMID: 36377885
PMC: 9769635.
DOI: 10.1128/spectrum.02489-22.
Systematic Metabolic Profiling Identifies Sphingolipid Synthesis as Hypha Associated and Essential for Candida albicans Filamentation.
Garbe E, Gerwien F, Driesch D, Muller T, Bottcher B, Graler M
mSystems. 2022; 7(6):e0053922.
PMID: 36264075
PMC: 9765226.
DOI: 10.1128/msystems.00539-22.
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A, Romaus-Sanjurjo D, Aramburu-Nunez M, Alvarez-Rafael D, Vazquez-Vazquez L, Camino-Castineiras J
Int J Mol Sci. 2022; 23(15).
PMID: 35897658
PMC: 9331765.
DOI: 10.3390/ijms23158082.
Involvement of Ceramide Metabolism in Cerebral Ischemia.
Ouro A, Correa-Paz C, Maqueda E, Custodia A, Aramburu-Nunez M, Romaus-Sanjurjo D
Front Mol Biosci. 2022; 9:864618.
PMID: 35531465
PMC: 9067562.
DOI: 10.3389/fmolb.2022.864618.
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
Tallon C, Picciolini S, Yoo S, Thomas A, Pal A, Alt J
Biochem Pharmacol. 2021; 194:114796.
PMID: 34678224
PMC: 8919377.
DOI: 10.1016/j.bcp.2021.114796.
Sphingolipids: Effectors and Achilles Heals in Viral Infections?.
Schneider-Schaulies S, Schumacher F, Wigger D, Schol M, Waghmare T, Schlegel J
Cells. 2021; 10(9).
PMID: 34571822
PMC: 8466362.
DOI: 10.3390/cells10092175.
Ceramides in Skin Health and Disease: An Update.
Uchida Y, Park K
Am J Clin Dermatol. 2021; 22(6):853-866.
PMID: 34283373
DOI: 10.1007/s40257-021-00619-2.
Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
Custodia A, Aramburu-Nunez M, Correa-Paz C, Posado-Fernandez A, Gomez-Larrauri A, Castillo J
Biomolecules. 2021; 11(7).
PMID: 34202192
PMC: 8301871.
DOI: 10.3390/biom11070945.
A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.
Quinville B, Deschenes N, Ryckman A, Walia J
Int J Mol Sci. 2021; 22(11).
PMID: 34071409
PMC: 8198874.
DOI: 10.3390/ijms22115793.
Inhibition of extracellular vesicle pathway using neutral sphingomyelinase inhibitors as a neuroprotective treatment for brain injury.
Kumar A, Kumar S
Neural Regen Res. 2021; 16(12):2349-2352.
PMID: 33907005
PMC: 8374560.
DOI: 10.4103/1673-5374.313014.
β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56 NK Cells.
Guan Z, Liu Y, Liu C, Wang H, Feng J, Yang G
Front Cell Infect Microbiol. 2021; 11:658141.
PMID: 33854984
PMC: 8039520.
DOI: 10.3389/fcimb.2021.658141.
Neutral sphingomyelinase-2 and cardiometabolic diseases.
Sindhu S, Leung Y, Arefanian H, Murthy Madiraju S, Al-Mulla F, Ahmad R
Obes Rev. 2021; 22(8):e13248.
PMID: 33738905
PMC: 8365731.
DOI: 10.1111/obr.13248.
The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.
de Wit N, Mol K, Rodriguez-Lorenzo S, de Vries H, Kooij G
Front Immunol. 2021; 11:620348.
PMID: 33633739
PMC: 7902029.
DOI: 10.3389/fimmu.2020.620348.
Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.
Skacel J, Slusher B, Tsukamoto T
J Med Chem. 2021; 64(1):279-297.
PMID: 33395289
PMC: 8023021.
DOI: 10.1021/acs.jmedchem.0c01664.